Human epidermal growth factor receptor 2 (HER2)-positive breast cancer refers to the amplification of the ERBB2/neu proto-oncogene or the overexpression of the HER2 transmembrane receptor protein. This evidence concerns the gene ERBB2 and breast carcinoma.